These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22310466)

  • 1. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
    Shiba-Ishii A; Noguchi M
    Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stratifin accelerates progression of lung adenocarcinoma at an early stage.
    Shiba-Ishii A; Kim Y; Shiozawa T; Iyama S; Satomi K; Kano J; Sakashita S; Morishita Y; Noguchi M
    Mol Cancer; 2015 Jul; 14():142. PubMed ID: 26223682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma.
    Shiba-Ishii A; Kano J; Morishita Y; Sato Y; Minami Y; Noguchi M
    Int J Cancer; 2011 Nov; 129(10):2445-53. PubMed ID: 21207417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stratifin Inhibits SCF
    Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M
    Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
    Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of stratifin in early progression of lung adenocarcinoma and its potential therapeutic relevance.
    Shiba-Ishii A
    Pathol Int; 2021 Oct; 71(10):655-665. PubMed ID: 34324245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
    Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH
    Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent aberrant methylation of the promoter region of sterile alpha motif domain 14 in pulmonary adenocarcinoma.
    Sun W; Iijima T; Kano J; Kobayashi H; Li D; Morishita Y; Okubo C; Anami Y; Noguchi M
    Cancer Sci; 2008 Nov; 99(11):2177-84. PubMed ID: 18823374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
    Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
    Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
    Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
    Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation profile of 14-3-3 sigma and its reduced transcription/expression levels in Chinese sporadic female breast carcinogenesis.
    Luo J; Feng J; Lu J; Wang Y; Tang X; Xie F; Li W
    Med Oncol; 2010 Sep; 27(3):791-7. PubMed ID: 19685192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
    Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I
    Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant OCIAD2 demethylation in lung adenocarcinoma is associated with outcome.
    Maki M; JeongMin H; Nakagawa T; Kawai H; Sakamoto N; Sato Y; Noguchi M
    Pathol Int; 2022 Oct; 72(10):496-505. PubMed ID: 35920378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypomethylation of the 14-3-3σ promoter leads to increased expression in non-small cell lung cancer.
    Radhakrishnan VM; Jensen TJ; Cui H; Futscher BW; Martinez JD
    Genes Chromosomes Cancer; 2011 Oct; 50(10):830-6. PubMed ID: 21755566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.
    Suzuki M; Shigematsu H; Shames DS; Sunaga N; Takahashi T; Shivapurkar N; Iizasa T; Minna JD; Fujisawa T; Gazdar AF
    Ann Surg Oncol; 2007 Apr; 14(4):1397-404. PubMed ID: 17195088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of 5'-CpG island hypermethylation of the FHIT gene with lung cancer in southern-central Chinese population.
    Li W; Deng J; Jiang P; Tang J
    Cancer Biol Ther; 2010 Nov; 10(10):997-1000. PubMed ID: 20814237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients.
    Mirza S; Sharma G; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Clin Biochem; 2010 Mar; 43(4-5):380-6. PubMed ID: 19961842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.